Zimmer Holdings Inc. (ZMH) Chairman, Eur., Afr., & M.East Bruno A Melzi sells 3,474 Shares

Chairman, Eur., Afr., & M.East of Zimmer Holdings Inc. (ZMH, Financial) Bruno A Melzi sells 3,474 shares of ZMH on 12/24/2009 at an average price of $60.03 a share.

Zimmer is a global leader in the design, development, manufacturing and market of reconstructive orthopaedic implants and fracture management products. Orthopaedic reconstruction implants restore joint function lost to disease or trauma in joints such as knees, hips, shoulders and elbows. Fracture management products are devices used primarily to reattach or stabilize damaged bone and tissue to support the body's natural healing process. Zimmer Holdings Inc. has a market cap of $12.84 billion; its shares were traded at around $60.27 with a P/E ratio of 15.74 and P/S ratio of 3.11. Zimmer Holdings Inc. had an annual average earning growth of 24.6% over the past 5 years.

ZMH is in the portfolios of Richard Pzena of Pzena Investment Management LLC, Chris Shumway of Shumway Capital Partners LLC, Private Capital of Private Capital Management, Robert Olstein of Olstein Financial Alert Fund, Eric Mindich of Eton Park Capital Management, L.P., Ronald Muhlenkamp of Muhlenkamp Fund, Bill Frels of MAIRS & POWER INC, John Rogers of ARIEL CAPITAL MANAGEMENT LLC, David Dreman of Dreman Value Management, HOTCHKIS & WILEY of HOTCHKIS & WILEY Capital Management LLC, Ron Baron of Baron Funds, Jeremy Grantham of GMO LLC, Edward Owens of Vanguard Health Care Fund, Paul Tudor Jones of The Tudor Group, Chuck Royce of ROYCE & ASSOCIATES, Bruce Kovner of Caxton Associates, Jean-Marie Eveillard of Arnhold & S. Bleichroeder Advisers, LLC.